Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients. [electronic resource]
Producer: 20090402Description: 2050-9 p. digitalISSN:- 1097-0215
- Anticarcinogenic Agents -- pharmacology
- Biomarkers, Tumor -- genetics
- Blotting, Western
- Cell Proliferation -- drug effects
- Cells, Cultured
- Cyclin-Dependent Kinase Inhibitor p21 -- genetics
- Cyclooxygenase 2 -- genetics
- Dinoprostone -- metabolism
- Double-Blind Method
- Gene Expression Regulation, Neoplastic -- drug effects
- Genistein -- pharmacology
- Humans
- Hydroxyprostaglandin Dehydrogenases -- genetics
- Isoflavones -- pharmacology
- Luciferases -- metabolism
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Recurrence, Local
- Neoplasms, Hormone-Dependent -- drug therapy
- Pilot Projects
- Promoter Regions, Genetic
- Prostatectomy
- Prostatic Neoplasms -- drug therapy
- RNA, Messenger -- genetics
- Receptors, Prostaglandin -- genetics
- Signal Transduction
- Soy Foods
- Transfection
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.